Related references
Note: Only part of the references are listed.Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
Tetsuya Taniguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study)
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study
Anne-Kathrin Tausche et al.
RHEUMATOLOGY (2017)
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout Findings of a Phase III Clinical Trial
Nicola Dalbeth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
Dipankar Sircar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
Tatsuo Hosoya et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Changes in serum uric acid have a reciprocal effect on eGFR change: a 10-year follow-up study of community-based screening in Okinawa, Japan
Kunitoshi Iseki et al.
HYPERTENSION RESEARCH (2013)
A two-stage approach to the treatment of hyperuricemia in gout: The Dirty Dish hypothesis
Fernando Perez-Ruiz et al.
ARTHRITIS AND RHEUMATISM (2011)
JAPANESE GUIDELINE FOR THE MANAGEMENT OF HYPERURICEMIA AND GOUT: SECOND EDITION
Hisashi Yamanaka
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
Share Paper
